{
  "image_filename": "table_p1_det_0_013.png",
  "image_path": "Liu_et_al.__2024_/extracted/figures/table_p1_det_0_013.png",
  "image_type": "Table",
  "page_number": 1,
  "block_id": "det_0_013",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A textual excerpt from page 1 of a Nature Communications article, showing introductory paragraphs about influenza viruses, annual vaccination recommendations, and descriptions of conventional egg-based (IIV4), cell-based (ccIIV4), and recombinant (RIV4) quadrivalent influenza vaccines, including mention of study NCT03722589 and exploratory immunogenicity analyses. does not support the claim because the displayed content does not provide any data or statements demonstrating that Flublok (the recombinant RIV4 vaccine) ensures an identical antigenic match with WHO- and FDA-selected flu strains. Note: No table data visible in the provided image; only narrative text is shown, so relevant evidence may appear elsewhere in the document.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A textual excerpt from page 1 of a Nature Communications article, showing introductory paragraphs about influenza viruses, annual vaccination recommendations, and descriptions of conventional egg-based (IIV4), cell-based (ccIIV4), and recombinant (RIV4) quadrivalent influenza vaccines, including mention of study NCT03722589 and exploratory immunogenicity analyses.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the displayed content does not provide any data or statements demonstrating that Flublok (the recombinant RIV4 vaccine) ensures an identical antigenic match with WHO- and FDA-selected flu strains.",
    "confidence_notes": "No table data visible in the provided image; only narrative text is shown, so relevant evidence may appear elsewhere in the document."
  }
}